- Home
- INO vs RMMZ Comparison
INO vs RMMZ Comparison
Compare INO & RMMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INO | RMMZ |
|---|---|---|
| Founded | 1979 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.6M | 123.9M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | RMMZ |
|---|---|---|
| Price | $2.27 | $14.70 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 25.6K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | ★ $182,337.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21,219.94 | N/A |
| P/E Ratio | ★ N/A | $19.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $12.92 |
| 52 Week High | $4.08 | $16.99 |
Technical Indicators
Market Signals| Indicator | INO | RMMZ |
|---|---|---|
| Relative Strength Index (RSI) | 59.44 | 47.44 |
| Support Level | $1.86 | $14.68 |
| Resistance Level | $2.27 | $14.88 |
| Average True Range (ATR) | 0.14 | 0.17 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 82.94 | 48.99 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About RMMZ RiverNorth Managed Duration Municipal Income Fund II Inc.
RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.